{"id":8340,"date":"2022-05-11T15:33:17","date_gmt":"2022-05-11T13:33:17","guid":{"rendered":"http:\/\/mohnfoundation.webforslag.com\/thematic-initiatives\/nasjonalt-forskningsprogram-innen-pet-nukleaermedisin-180on\/"},"modified":"2025-12-15T11:37:00","modified_gmt":"2025-12-15T10:37:00","slug":"national-research-program-in-pet-nuclear-medicine-180n","status":"publish","type":"page","link":"https:\/\/mohnfoundation.no\/en\/https-mohnfoundation-no-en-thematic-initiatives-womens-health\/national-research-program-in-pet-nuclear-medicine-180n\/","title":{"rendered":"National research program in PET-Nuclear medicine; 180\u00b0N"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row css=&#8221;.vc_custom_1671716393743{margin-right: 0px !important;margin-left: 0px !important;background-image: url(https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/12\/Nucleus.png?id=9549) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}&#8221;][vc_column]<div class=\"spacer-5830a5ea62c1f2880975a2ceab4a96be2\" style=\"\"><\/div><style>@media (min-width: 320px) { .spacer-5830a5ea62c1f2880975a2ceab4a96be2{ height: 200px;}}@media (min-width: 767px) { .spacer-5830a5ea62c1f2880975a2ceab4a96be2{ height: 200px;}}@media (min-width: 979px) { .spacer-5830a5ea62c1f2880975a2ceab4a96be2{ height: 400px;}}@media (min-width: 1200px) { .spacer-5830a5ea62c1f2880975a2ceab4a96be2{ height: 400px;}}<\/style>[\/vc_column][\/vc_row][vc_row el_class=&#8221;article-white&#8221; css=&#8221;.vc_custom_1649538946065{margin-right: 0px !important;margin-left: 0px !important;}&#8221;][vc_column][vc_row_inner][vc_column_inner width=&#8221;1\/6&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243;]\n\t\t\t<figure class=\"standard-image left no-caption\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1253\" height=\"200\" src=\"https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/180N_toppbanner_fargebakgrunn.png\" class=\"attachment- size-\" alt=\"\" srcset=\"https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/180N_toppbanner_fargebakgrunn.png 1253w, https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/180N_toppbanner_fargebakgrunn-300x48.png 300w, https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/180N_toppbanner_fargebakgrunn-1024x163.png 1024w, https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/180N_toppbanner_fargebakgrunn-768x123.png 768w, https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/180N_toppbanner_fargebakgrunn-320x51.png 320w, https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/180N_toppbanner_fargebakgrunn-420x67.png 420w, https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/180N_toppbanner_fargebakgrunn-576x92.png 576w, https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/180N_toppbanner_fargebakgrunn-992x158.png 992w, https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/180N_toppbanner_fargebakgrunn-1200x192.png 1200w\" sizes=\"auto, (max-width: 1253px) 100vw, 1253px\" \/>\n\t\t\t\t\n\t\t\t<\/figure>[\/vc_column_inner][vc_column_inner width=&#8221;1\/6&#8243;][\/vc_column_inner][\/vc_row_inner][vc_row_inner css=&#8221;.vc_custom_1650537879673{margin-bottom: -30px !important;}&#8221;][vc_column_inner]<div class=\"header left  \"><h1 class=\"font-size-sm\" title=\"National research program in PET-Nuclear medicine; 180\u00b0N\">National research program in PET-Nuclear medicine; 180\u00b0N<\/h1><\/div>[\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_column_text]Trond Mohn Foundation (TMF) and Troms\u00f8 Research Foundation (TRF) have a common goal to enhance the impact of Trond Mohn\u00b4s private donations; PET scanners to the university hospitals in Bergen Troms\u00f8 and Trondheim. This ambition was realized by a national research programme pointed at the scientific strengths identified by the research communities at three PET facilities with strong expectations of national cooperation and sharing of best practice.<\/p>\n<p><strong>NEW: 180\u00b0N Conference 2023 in Bergen, April 25.-27. Link with more information will follow soon.<\/strong>[\/vc_column_text][vc_video link=&#8221;https:\/\/youtu.be\/oqqFdUznHeg&#8221;][vc_column_text]<\/p>\n<h3>Three topics: Tracer development, preclinical and clinical research<\/h3>\n<p>\u2018This co-funding programme with a total value of NOK 160 million gives researchers working in the field of neurological disorders and cancer a fantastic opportunity to develop new treatment methods,\u2019 says Bent H\u00f8ie. \u2018Research is a precondition for improving quality in the specialist health service. I am grateful that the foundations\u2019 donations have made it possible to undertake this significant research initiative, and have great expectations that the results generated from this work will benefit patients.\u2019<\/p>\n<div>\n<article id=\"post-5396\">The \u2018recurrent theme\u2019 for the research programme is to develop methods that can help to ensure more targeted treatment for different types of cancer and neurological disorders (dementia). In short, this is done by the patients being injected with a new type of tracer (radioactive trace elements) that improve the imaging of e.g. tumours before surgical procedures. This makes it possible to determine the location of tumours with greater accuracy, which allows for more effective and less drastic patient treatment.<\/article>\n<article>Cooperation as a success factorResearchers at the three institutions have different approaches to this thematic area and will work closely together, in part because the hospitals have the same state-of-the-art diagnostic imaging equipment allowing simple exchange of information. This equipment has been partly financed by private donations from Trond Mohn to the university hospitals in Bergen, Trondheim and Troms\u00f8. The two foundations are helping to add further value to these donations by way of this major research initiative. The institutions themselves have developed their respective projects in cooperation, and the foundations have found them worthy of support, not least due to the major benefits they can bring about for cancer patientsWith identical diagnostic imaging equipment in place, everything is set for sharing methods and procedures between researchers in Troms\u00f8, Trondheim and Bergen, and sharing knowledge and data from the respective specialist fields can also help to enhance the projects.To target their efforts under this collaboration programme, the research communities in the three cities have selected their respective focus areas. Troms\u00f8 will take preclinical trials as their point of departure, while Trondheim will base its work on clinical trials. Bergen will build on its experience of developing radioactive tracers (radiotracers). After two rounds of evaluation of the project applications by a panel comprising leading national and international experts, the foundations decided to award NOK 25 million to each of the three projects. A further NOK 5 million will go to further strengthening the national and international collaboration. The research programme will start up in 2019 and run until 2024.<\/p>\n<h3>Projects coordinated from three cities<\/h3>\n<p>The project at Haukeland University Hospital in Bergen, led by Associate Professor Tom Christian Holm Adamsen, will focus on chemical innovation to increase the number of new diagnostic and therapeutic tools available in nuclear medicine, a medical specialisation that uses open radioactive substances in diagnostics and therapy.<\/p>\n<p>The project at the PET centre in Troms\u00f8, led by Associate Professor Rune Sundset, will comprise preclinical research using cancer cells and mice. Radiopharmaceuticals for use in PET (positron emission tomography) and nuclear medicine will be tested in the new pre-clinical facilities at the PET centre in Troms\u00f8 using state-of-the-art infrastructure for pre-clinical research in nuclear medicine and radiation biology.<\/p>\n<p>The project in Trondheim, led by Professor Tone Bathen at the Norwegian University of Science and Technology (NTNU), will work on developing and documenting optimal diagnostics and treatment. This will be done by conducting multi-centre studies based on large and relevant patient groups, such as patients with prostate cancer, brain tumours and dementia.<\/p>\n<p>In addition to each of the projects involving researchers from all universities and university hospitals in Bergen, Trondheim and Troms\u00f8, Stavanger University Hospital will also participate as a partner in one of the projects.<\/p>\n<p>\u2013 Something we need more of<\/p>\n<p>\u2013Norway needs high-quality research to create better services, treatment and patient services going forward,\u2019 said former Director General of the Research Council of Norway John-Arne R\u00f8ttingen. \u2018To achieve these goals, we need both public and private funding. I think it is excellent that private actors and foundations such as Trond Mohn and Troms\u00f8 Research Centre help to enhance health research by stimulating collaboration across disciplines and regions. This is something we need more of, R\u00f8ttingen said.<\/p>\n<p>\u2013 Will make a difference<\/p>\n<p>The Trond Mohn Foundation and Troms\u00f8 Research Centre want to make a real difference in terms of both discipline development and the patient treatment of the future, something this programme undoubtedly has the potential to do,\u2019 said Stener Kvinnsland, chair of the Trond Mohn Foundation.<\/p>\n<p>\u2018We hope the foundations\u2019 initiative can encourage greater collaboration between Norwegian expert communities in this field for the benefit of patients, and look forward to following these research projects,\u2019 said Sveinung Hole, CEO of the Trond Mohn Foundation and chair of Troms\u00f8 Research Centre.<\/p>\n<h3>cooperative project<\/h3>\n<p>The overarching aim of the 180\u00b0N project is to strengthen research in nuclear medicine connected to the nuclear medicine equipment donated by Trond Mohn Foundation and Troms\u00f8 Research Foundation to the universities and hospitals in Trondheim, Troms\u00f8 and Bergen.<\/p>\n<p>This additional joint cooperative project aims to stimulate consortium collaboration and to increase synergy effects between the research projects, thus facilitating the 180\u00b0N research projects to reach the goals. The measures are multifaceted;<\/p>\n<ol>\n<li>To establish an annual conference as a platform for knowledge exchange and network building within 180\u00b0N, but also as an arena to obtain stimuli and interact with international researchers and clinicians holding state of the art expertise<\/li>\n<li>To provide travel grants for skills enhancement<\/li>\n<li>To provide funding for work package meetings, collaborations and conference participation<\/li>\n<li>To hire a communication manager<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<p>Ingress illustration made by Tom Christian Adamsen<\/p>\n<\/article>\n<\/div>\n<p>[\/vc_column_text][vc_column_text][\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/3&#8243;]<div class=\"infobox light-brown\">\n<div class=\"wpb_text_column wpb_content_element \">\n<div class=\"wpb_wrapper\">\n<h4>News<\/h4>\n<p><a href=\"https:\/\/www.ntnu.edu\/180n\/2026conference\" target=\"_blank\" rel=\"noopener\">180\u00b0N Conference 2026 in Trondheim April 28 &#8211; 29.<\/a><\/p>\n<\/div>\n<\/div>\n<\/div><div class=\"external-links-container blue-download\"><ul class=\"external-links\"><li class=\"inner-item\"><i class=\"fa fa-external-link\"><\/i><a href=\"https:\/\/180n.no\/annual-report\/180n-annual-report-2020\/\" target=\"_blank\" rel=\"noopener\">Annual report 2020<\/a><\/li><\/ul><\/div><div class=\"external-links-container blue-download\"><ul class=\"external-links\"><li class=\"inner-item\"><i class=\"fa fa-external-link\"><\/i><a href=\"https:\/\/180n.no\/annual-report\/180n-annual-report-2021\/\" target=\"_blank\" rel=\"noopener\">Annual report 2021<\/a><\/li><\/ul><\/div><div class=\"external-links-container blue-download\"><ul class=\"external-links\"><li class=\"inner-item\"><i class=\"fa fa-external-link\"><\/i><a href=\"https:\/\/www.ntnu.edu\/documents\/1317620948\/1323597159\/AnnualRrport2022.pdf\/4f6c4a2f-403d-a955-3d06-73c303e829ac?t=1669986817596\" target=\"_blank\" rel=\"noopener\">Annual report 2022<\/a><\/li><\/ul><\/div><div class=\"external-links-container blue-download\"><ul class=\"external-links\"><li class=\"inner-item\"><i class=\"fa fa-external-link\"><\/i><a href=\"https:\/\/www.ntnu.edu\/documents\/1317620948\/1323597159\/180N_%C3%A5rsrapport_2023_web.pdf\/75eada9a-422e-d2a5-6c93-4e3ac27ff017?t=1700139944695\" target=\"_blank\" rel=\"noopener\">Annual report 2023<\/a><\/li><\/ul><\/div><div class=\"infobox light-brown\">\n<div class=\"wpb_text_column wpb_content_element \">\n<div class=\"wpb_wrapper\">\n<h4>Facts about the program<\/h4>\n<\/div>\n<\/div>\n<div class=\"wpb_text_column wpb_content_element \">\n<div class=\"wpb_wrapper\">\n<p><a href=\"https:\/\/180n.no\/\" target=\"_blank\" rel=\"noopener\">Program web page<\/a><br \/>\nProgram period: 2019-2024<br \/>\nFunding: 80 MNOK<\/p>\n<h4>About the prosjects:<\/h4>\n<p><strong>Project lead from Bergen<\/strong><\/p>\n<p>Title:\u00a0Center for Nuclear Medicine and PET<br \/>\nHost institution:\u00a0Haukeland University Hospital<br \/>\nProject leader:\u00a0<a href=\"mailto:tom.adamsen@uib.no\">Tom Chr. Holm Adamsen<\/a><br \/>\nTMS-funding:\u00a025 MNOK<\/p>\n<p><strong>Project lead from Trondheim<\/strong><\/p>\n<p>Title:\u00a0Improved diagnostics and treatment through a state-of-the-art multi-center nuclear medicine approach: Applications in cancer and dementia<br \/>\nHost institution:\u00a0Norwegian University of Science and Technology<br \/>\nProject leader:\u00a0<a href=\"mailto:tone.f.bathen@ntnu.no\">Tone F. Bathen<\/a><br \/>\nTMS-funding:\u00a025 MNOK<\/p>\n<p><strong>Project lead from Troms\u00f8<\/strong><\/p>\n<p>Title:\u00a0Targeting tumor microenvironment: Boosting PET-based diagnostics and therapies<br \/>\nHost institution:\u00a0UiT-\u00a0 The Arctic University of Norway<br \/>\nProject leader:\u00a0<a href=\"mailto:Rune.Sundset@unn.no\">Rune Sundset<\/a><br \/>\nTFS-funding:\u00a025 MNOK<\/p>\n<hr \/>\n<h4>Joint cooperative project<\/h4>\n<p>Title:\u00a0180\u00b0N \u2013 Norwegian Nuclear Medicine Consortium<br \/>\nHost institution:\u00a0Norges teknisk-naturvitenskapelige universitet<br \/>\nProject leader:\u00a0<a href=\"mailto:tone.f.bathen@ntnu.no\">T<\/a><a href=\"mailto:tone.f.bathen@ntnu.no\">one<\/a><a href=\"mailto:tone.f.bathen@ntnu.no\">\u00a0F. Bathen<\/a><br \/>\nDeputy leader:\u00a0<a href=\"https:\/\/www.ntnu.no\/ansatte\/live.eikenes\" target=\"_blank\" rel=\"noopener\">Live<\/a><a href=\"https:\/\/www.ntnu.no\/ansatte\/live.eikenes\" target=\"_blank\" rel=\"noopener\">\u00a0Eikenes<\/a><br \/>\nTMS-funding:\u00a05 MNOK<\/p>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t<figure class=\"standard-image left \">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"333\" height=\"333\" src=\"https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/Runde-Su..jpg\" class=\"attachment- size-\" alt=\"\" srcset=\"https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/Runde-Su..jpg 333w, https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/Runde-Su.-300x300.jpg 300w, https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/Runde-Su.-150x150.jpg 150w, https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/Runde-Su.-320x320.jpg 320w\" sizes=\"auto, (max-width: 333px) 100vw, 333px\" \/>\n\t\t\t\t<figcaption>Ass. professor Rune Sundseth<br>Universitetssykehuset Nord Norge\/UiT. Foto: Per-Christian Johansen<\/figcaption>\n\t\t\t<\/figure>\n\t\t\t<figure class=\"standard-image left \">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"333\" height=\"333\" src=\"https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/Tone-Frost-Bathen.jpg\" class=\"attachment- size-\" alt=\"\" srcset=\"https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/Tone-Frost-Bathen.jpg 333w, https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/Tone-Frost-Bathen-300x300.jpg 300w, https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/Tone-Frost-Bathen-150x150.jpg 150w, https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/Tone-Frost-Bathen-320x320.jpg 320w\" sizes=\"auto, (max-width: 333px) 100vw, 333px\" \/>\n\t\t\t\t<figcaption>Professor Tone Frost Bathen<br>NTNU: Foto Karl J\u00f8rgen Marthinsen<\/figcaption>\n\t\t\t<\/figure>\n\t\t\t<figure class=\"standard-image left \">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"333\" height=\"333\" src=\"https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/tomadamsen..jpg\" class=\"attachment- size-\" alt=\"\" srcset=\"https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/tomadamsen..jpg 333w, https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/tomadamsen.-300x300.jpg 300w, https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/tomadamsen.-150x150.jpg 150w, https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/tomadamsen.-320x320.jpg 320w\" sizes=\"auto, (max-width: 333px) 100vw, 333px\" \/>\n\t\t\t\t<figcaption>F\u00f8rsteamanuensis Tom Chr. Holm Adamsen<br>Haukeland universitetssykehus\/UiB. Foto: J\u00f8rgen Barth\/UiB<\/figcaption>\n\t\t\t<\/figure>\n\t\t\t<figure class=\"standard-image left \">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"333\" height=\"333\" src=\"https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/Professor-Live-Eikenes.jpg\" class=\"attachment- size-\" alt=\"\" srcset=\"https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/Professor-Live-Eikenes.jpg 333w, https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/Professor-Live-Eikenes-300x300.jpg 300w, https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/Professor-Live-Eikenes-150x150.jpg 150w, https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/05\/Professor-Live-Eikenes-320x320.jpg 320w\" sizes=\"auto, (max-width: 333px) 100vw, 333px\" \/>\n\t\t\t\t<figcaption>Professor Live Eikenes<br>NTNU: Foto Karl J\u00f8rgen Marthinsen<\/figcaption>\n\t\t\t<\/figure>[\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column]<div class=\"spacer-3ed3c4f3188960fecee6faed144db8791289\" style=\"\"><\/div><style>@media (min-width: 320px) { .spacer-3ed3c4f3188960fecee6faed144db8791289{ height: 30px;}}@media (min-width: 767px) { .spacer-3ed3c4f3188960fecee6faed144db8791289{ height: 30px;}}@media (min-width: 979px) { .spacer-3ed3c4f3188960fecee6faed144db8791289{ height: 60px;}}@media (min-width: 1200px) { .spacer-3ed3c4f3188960fecee6faed144db8791289{ height: 60px;}}<\/style>[\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row css=&#8221;.vc_custom_1671716393743{margin-right: 0px !important;margin-left: 0px !important;background-image: url(https:\/\/mohnfoundation.no\/wp-content\/uploads\/2022\/12\/Nucleus.png?id=9549) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}&#8221;][vc_column][\/vc_column][\/vc_row][vc_row el_class=&#8221;article-white&#8221; css=&#8221;.vc_custom_1649538946065{margin-right: 0px !important;margin-left: 0px !important;}&#8221;][vc_column][vc_row_inner][vc_column_inner width=&#8221;1\/6&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;1\/6&#8243;][\/vc_column_inner][\/vc_row_inner][vc_row_inner css=&#8221;.vc_custom_1650537879673{margin-bottom: -30px !important;}&#8221;][vc_column_inner][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_column_text]Trond Mohn Foundation (TMF) and Troms\u00f8 Research Foundation (TRF) [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary vidiflex-read-more-link\" href=\"https:\/\/mohnfoundation.no\/en\/https-mohnfoundation-no-en-thematic-initiatives-womens-health\/national-research-program-in-pet-nuclear-medicine-180n\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"parent":8283,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"class_list":["post-8340","page","type-page","status-publish","hentry"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-22 21:41:07","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"translation_priority","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/mohnfoundation.no\/en\/wp-json\/wp\/v2\/pages\/8340","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mohnfoundation.no\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/mohnfoundation.no\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/mohnfoundation.no\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/mohnfoundation.no\/en\/wp-json\/wp\/v2\/comments?post=8340"}],"version-history":[{"count":13,"href":"https:\/\/mohnfoundation.no\/en\/wp-json\/wp\/v2\/pages\/8340\/revisions"}],"predecessor-version":[{"id":13215,"href":"https:\/\/mohnfoundation.no\/en\/wp-json\/wp\/v2\/pages\/8340\/revisions\/13215"}],"up":[{"embeddable":true,"href":"https:\/\/mohnfoundation.no\/en\/wp-json\/wp\/v2\/pages\/8283"}],"wp:attachment":[{"href":"https:\/\/mohnfoundation.no\/en\/wp-json\/wp\/v2\/media?parent=8340"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}